The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time
Transplant International · 2023
DOI: 10.3389/ti.2023.11633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2023. Verfasst von Lorenzo Piemonti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Institute, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Tissue Engineering. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The field of transplantation has witnessed the emergence of Advanced Therapy Medicinal Products (ATMPs) as highly promising solutions to address the challenges associated with organ and tissue transplantation. ATMPs encompass gene therapy, cell therapy, and tissue-engineered products, hold immense potential for breakthroughs in overcoming the obstacles of rejection and the limited availability of donor organs. However, the development and academic research access to ATMPs face significant bottlenecks that hinder progress. This opinion paper emphasizes the importance of addressing bottlenecks in the development and academic research access to ATMPs by implementing several key strategies. These include the establishment of streamlined regulatory processes, securing increased funding for ATMP research, fostering collaborations and partnerships, setting up centralized ATMP facilities, and actively engaging with patient groups. Advocacy at the policy level is essential to provide support for the development and accessibility of ATMPs, thereby driving advancements in transplantation and enhancing patient outcomes. By adopting these strategies, the field of transplantation can pave the way for the introduction of innovative and efficacious ATMP therapies, while simultaneously fostering a nurturing environment for academic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Research Institute, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.
- Department of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
- Department of Medical Ethics, Philosophy and History of Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
- Department of Nephrology and Transplantation, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
- Université de Lille, INSERM, Campus Hospitalo-Universitaire de Lille, Institut Pasteur de Lille, U1190-EGID, Lille, France.
- Department CBITE, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, Netherlands.
Zitieren
APA
Piemonti, L., Scholz, H., de Jongh, D., Kerr-Conte, J., van Apeldoorn, A., Shaw, J. A. M., Engelse, M. A., Bunnik, E., Mühlemann, M., Pal-Kutas, K., Scott, W. E., Magalon, J., Kugelmeier, P., & Berishvili, E. (2023). The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time. Transplant International. https://doi.org/10.3389/ti.2023.11633
Vancouver
Piemonti L, Scholz H, de Jongh D, Kerr-Conte J, van Apeldoorn A, Shaw JAM, et al. The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time. Transplant International. 2023. doi:10.3389/ti.2023.11633
BibTeX
@article{Piemonti2023,
author = {Piemonti, Lorenzo and Scholz, Hanne and de Jongh, Dide and Kerr-Conte, Julie and van Apeldoorn, Aart and Shaw, James A M and Engelse, Marten A and Bunnik, Eline and Mühlemann, Markus and Pal-Kutas, Karolina and Scott, William E and Magalon, Jérémy and Kugelmeier, Patrick and Berishvili, Ekaterine},
title = {The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time},
journal = {Transplant International},
year = {2023},
doi = {10.3389/ti.2023.11633}
}
EUVIMED